Literature DB >> 21289614

Autoinflammation in 2010: expanding clinical spectrum and broadening therapeutic horizons.

Michael J Ombrello1, Daniel L Kastner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21289614      PMCID： PMC3393888          DOI： 10.1038/nrrheum.2010.229

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra.

Authors:  Loredana Lepore; Giulia Paloni; Roberta Caorsi; Maria Alessio; Donato Rigante; Nicola Ruperto; Marco Cattalini; Alberto Tommasini; Francesco Zulian; Alessando Ventura; Alberto Martini; Marco Gattorno
Journal:  J Pediatr       Date:  2010-05-15       Impact factor: 4.406

Review 2.  Cryopyrin-associated periodic syndromes: background and therapeutics.

Authors:  Tetsuo Kubota; Ryuji Koike
Journal:  Mod Rheumatol       Date:  2010-02-06       Impact factor: 3.023

3.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Authors:  M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

4.  Autoinflammatory disease reloaded: a clinical perspective.

Authors:  Daniel L Kastner; Ivona Aksentijevich; Raphaela Goldbach-Mansky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

6.  Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.

Authors:  Karl Bodin; Stephan Ellmerich; Melvyn C Kahan; Glenys A Tennent; Andrzej Loesch; Janet A Gilbertson; Winston L Hutchinson; Palma P Mangione; J Ruth Gallimore; David J Millar; Shane Minogue; Amar P Dhillon; Graham W Taylor; Arthur R Bradwell; Aviva Petrie; Julian D Gillmore; Vittorio Bellotti; Marina Botto; Philip N Hawkins; Mark B Pepys
Journal:  Nature       Date:  2010-10-20       Impact factor: 49.962

7.  Blocking interleukin-1 in rheumatic diseases.

Authors:  Raphaela Goldbach-Mansky
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

Review 8.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

Authors:  Seth L Masters; Anna Simon; Ivona Aksentijevich; Daniel L Kastner
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Authors:  Bénédicte Neven; Isabelle Marvillet; Celine Terrada; Alice Ferster; Nathalie Boddaert; Vincent Couloignier; Graziella Pinto; Anne Pagnier; Christine Bodemer; Bahram Bodaghi; Marc Tardieu; Anne Marie Prieur; Pierre Quartier
Journal:  Arthritis Rheum       Date:  2010-01

10.  Natural history and outcome in systemic AA amyloidosis.

Authors:  Helen J Lachmann; Hugh J B Goodman; Janet A Gilbertson; J Ruth Gallimore; Caroline A Sabin; Julian D Gillmore; Philip N Hawkins
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245
  10 in total
  8 in total

1.  Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease.

Authors:  Andrea Vambutas; Martin Lesser; Virginia Mullooly; Shresh Pathak; Gerald Zahtz; Lisa Rosen; Elliot Goldofsky
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

2.  IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.

Authors:  Te-Chia Wu; Kangling Xu; Jan Martinek; Robyn R Young; Romain Banchereau; Joshy George; Jacob Turner; Kyung In Kim; Sandra Zurawski; Xuan Wang; Derek Blankenship; Hannah M Brookes; Florentina Marches; Gerlinde Obermoser; Elizabeth Lavecchio; Maren K Levin; Sookyoung Bae; Cheng-Han Chung; Jennifer L Smith; Alma-Martina Cepika; Kyp L Oxley; George J Snipes; Jacques Banchereau; Virginia Pascual; Joyce O'Shaughnessy; A Karolina Palucka
Journal:  Cancer Res       Date:  2018-07-16       Impact factor: 12.701

3.  Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis.

Authors:  Tomoyuki Iwasaki; Naoe Kaneko; Yuki Ito; Hiroyuki Takeda; Tatsuya Sawasaki; Toshio Heike; Kiyoshi Migita; Kazunaga Agematsu; Atsushi Kawakami; Shinnosuke Morikawa; Sho Mokuda; Mie Kurata; Junya Masumoto
Journal:  ScientificWorldJournal       Date:  2016-06-15

Review 4.  AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss.

Authors:  Andrea Vambutas; Shresh Pathak
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-09-21

5.  Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis.

Authors:  Yongting Luo; Hongxia Duan; Yining Qian; Liqun Feng; Zhenzhen Wu; Fei Wang; Jing Feng; Dongling Yang; Zhihai Qin; Xiyun Yan
Journal:  Cell Res       Date:  2017-01-13       Impact factor: 25.617

Review 6.  Applications of reconstituted inflammasomes in a cell-free system to drug discovery and elucidation of the pathogenesis of autoinflammatory diseases.

Authors:  Naoe Kaneko; Tomoyuki Iwasaki; Yuki Ito; Hiroyuki Takeda; Tatsuya Sawasaki; Shinnosuke Morikawa; Naoko Nakano; Mie Kurata; Junya Masumoto
Journal:  Inflamm Regen       Date:  2017-05-03

7.  Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever.

Authors:  Samia Salah El-Din Mahmoud; Nagwa Abdallah Ismail; Yomna Mohamed Farag; Rania Hamdy Hashem; Mona Hamed Ibrahim; Mohab Mohamed Salah; Andrew Nasif Tous
Journal:  Arch Med Sci Atheroscler Dis       Date:  2018-08-07

8.  Thorough investigation of a canine autoinflammatory disease (AID) confirms one main risk locus and suggests a modifier locus for amyloidosis.

Authors:  Mia Olsson; Linda Tintle; Marcin Kierczak; Michele Perloski; Noriko Tonomura; Andrew Lundquist; Eva Murén; Max Fels; Katarina Tengvall; Gerli Pielberg; Caroline Dufaure de Citres; Laetitia Dorso; Jérôme Abadie; Jeanette Hanson; Anne Thomas; Peter Leegwater; Åke Hedhammar; Kerstin Lindblad-Toh; Jennifer R S Meadows
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.